HK Stock MarketDetailed Quotes

02190 ZYLOXTB-B

Watchlist
  • 10.280
  • +0.040+0.39%
Trading Apr 26 13:00 CST
3.42BMarket Cap-39386P/E (TTM)

ZYLOXTB-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
57.97%527.75M
50.67%230.13M
87.78%334.09M
113.67%152.74M
543.89%177.91M
--71.48M
461.95%27.63M
--4.92M
Operating income
57.97%527.75M
50.67%230.13M
87.78%334.09M
113.67%152.74M
543.89%177.91M
71.48M
461.95%27.63M
4.92M
Cost of sales
-75.34%-142.77M
-59.62%-59.49M
-76.88%-81.42M
-92.49%-37.27M
-305.77%-46.03M
---19.36M
-204.54%-11.34M
---3.73M
Operating expenses
-75.34%-142.77M
-59.62%-59.49M
-76.88%-81.42M
-92.49%-37.27M
-305.77%-46.03M
-19.36M
-204.54%-11.34M
-3.73M
Gross profit
52.37%384.99M
47.77%170.65M
91.59%252.67M
121.54%115.48M
709.73%131.88M
52.12M
1,266.36%16.29M
1.19M
Selling expenses
-16.90%-163.83M
-40.52%-74.94M
-47.10%-140.14M
-107.13%-53.33M
-365.79%-95.27M
---25.75M
-202.60%-20.45M
---6.76M
Administrative expenses
-4.35%-114.09M
-2.18%-50.36M
-8.69%-109.34M
9.01%-49.28M
-224.60%-100.6M
---54.16M
-82.71%-30.99M
---16.96M
Research and development expenses
-11.80%-261.01M
-39.10%-130.81M
-38.88%-233.46M
-92.00%-94.04M
-133.26%-168.1M
---48.98M
-35.90%-72.07M
---53.03M
Impairment and provision
37.50%-15K
-160.00%-6K
-14.29%-24K
--10K
---21K
----
----
----
-Other impairment is provision
37.50%-15K
-160.00%-6K
-14.29%-24K
--10K
---21K
----
----
----
Special items of operating profit
-111.73%-2.57M
-42.75%11.33M
11.51%21.89M
307.89%19.79M
178.03%19.63M
--4.85M
-28.36%7.06M
--9.86M
Operating profit
24.89%-156.52M
-20.78%-74.13M
1.92%-208.4M
14.65%-61.38M
-112.13%-212.48M
-71.91M
-52.45%-100.16M
-65.7M
Financing income
-17.29%79.04M
8.13%39.26M
629.84%95.57M
1,485.33%36.3M
3,537.22%13.09M
--2.29M
304.49%360K
--89K
Financing cost
-73.27%-1.25M
19.91%-346K
-135.18%-722K
-364.52%-432K
53.90%-307K
---93K
35.65%-666K
---1.04M
Earning before tax
30.66%-78.73M
-38.11%-35.22M
43.13%-113.56M
63.42%-25.5M
-98.76%-199.69M
-69.72M
-50.75%-100.47M
-66.65M
Tax
----
---291K
----
----
----
----
----
----
After-tax profit from continuing operations
30.66%-78.73M
-39.25%-35.51M
43.13%-113.56M
63.42%-25.5M
-98.76%-199.69M
-69.72M
-50.75%-100.47M
-66.65M
Earning after tax
30.66%-78.73M
-39.25%-35.51M
43.13%-113.56M
63.42%-25.5M
-98.76%-199.69M
-69.72M
-50.75%-100.47M
-66.65M
Profit attributable to shareholders
30.66%-78.73M
-39.25%-35.51M
43.13%-113.56M
63.42%-25.5M
-98.76%-199.69M
-69.72M
-50.75%-100.47M
-66.65M
Basic earnings per share
29.41%-0.24
-37.50%-0.11
50.00%-0.34
70.37%-0.08
-30.77%-0.68
-0.27
-36.84%-0.52
-0.38
Diluted earnings per share
29.41%-0.24
-37.50%-0.11
50.00%-0.34
70.37%-0.08
-30.77%-0.68
-0.27
-36.84%-0.52
-0.38
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
PricewaterhouseCoopers
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 57.97%527.75M50.67%230.13M87.78%334.09M113.67%152.74M543.89%177.91M--71.48M461.95%27.63M--4.92M
Operating income 57.97%527.75M50.67%230.13M87.78%334.09M113.67%152.74M543.89%177.91M71.48M461.95%27.63M4.92M
Cost of sales -75.34%-142.77M-59.62%-59.49M-76.88%-81.42M-92.49%-37.27M-305.77%-46.03M---19.36M-204.54%-11.34M---3.73M
Operating expenses -75.34%-142.77M-59.62%-59.49M-76.88%-81.42M-92.49%-37.27M-305.77%-46.03M-19.36M-204.54%-11.34M-3.73M
Gross profit 52.37%384.99M47.77%170.65M91.59%252.67M121.54%115.48M709.73%131.88M52.12M1,266.36%16.29M1.19M
Selling expenses -16.90%-163.83M-40.52%-74.94M-47.10%-140.14M-107.13%-53.33M-365.79%-95.27M---25.75M-202.60%-20.45M---6.76M
Administrative expenses -4.35%-114.09M-2.18%-50.36M-8.69%-109.34M9.01%-49.28M-224.60%-100.6M---54.16M-82.71%-30.99M---16.96M
Research and development expenses -11.80%-261.01M-39.10%-130.81M-38.88%-233.46M-92.00%-94.04M-133.26%-168.1M---48.98M-35.90%-72.07M---53.03M
Impairment and provision 37.50%-15K-160.00%-6K-14.29%-24K--10K---21K------------
-Other impairment is provision 37.50%-15K-160.00%-6K-14.29%-24K--10K---21K------------
Special items of operating profit -111.73%-2.57M-42.75%11.33M11.51%21.89M307.89%19.79M178.03%19.63M--4.85M-28.36%7.06M--9.86M
Operating profit 24.89%-156.52M-20.78%-74.13M1.92%-208.4M14.65%-61.38M-112.13%-212.48M-71.91M-52.45%-100.16M-65.7M
Financing income -17.29%79.04M8.13%39.26M629.84%95.57M1,485.33%36.3M3,537.22%13.09M--2.29M304.49%360K--89K
Financing cost -73.27%-1.25M19.91%-346K-135.18%-722K-364.52%-432K53.90%-307K---93K35.65%-666K---1.04M
Earning before tax 30.66%-78.73M-38.11%-35.22M43.13%-113.56M63.42%-25.5M-98.76%-199.69M-69.72M-50.75%-100.47M-66.65M
Tax -------291K------------------------
After-tax profit from continuing operations 30.66%-78.73M-39.25%-35.51M43.13%-113.56M63.42%-25.5M-98.76%-199.69M-69.72M-50.75%-100.47M-66.65M
Earning after tax 30.66%-78.73M-39.25%-35.51M43.13%-113.56M63.42%-25.5M-98.76%-199.69M-69.72M-50.75%-100.47M-66.65M
Profit attributable to shareholders 30.66%-78.73M-39.25%-35.51M43.13%-113.56M63.42%-25.5M-98.76%-199.69M-69.72M-50.75%-100.47M-66.65M
Basic earnings per share 29.41%-0.24-37.50%-0.1150.00%-0.3470.37%-0.08-30.77%-0.68-0.27-36.84%-0.52-0.38
Diluted earnings per share 29.41%-0.24-37.50%-0.1150.00%-0.3470.37%-0.08-30.77%-0.68-0.27-36.84%-0.52-0.38
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopersPricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg